The effects of statins on prevention of stroke and dementia: a review

Related Experiment Video

Updated: May 20, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Arthur R Menezes1, Carl J Lavie, Richard V Milani

  • 1Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner, Clinical School-The University of Queensland School of Medicine, New Orleans, Louisiana, USA.

Journal of Cardiopulmonary Rehabilitation and Prevention
|July 13, 2012
PubMed

Insights

Statins significantly reduce stroke risk, particularly in older adults. These cholesterol-lowering drugs also offer neuroprotective benefits, though their role in preventing dementia remains under investigation.

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Stroke is a leading cause of death and healthcare expenditure, with prevalence increasing with age.
  • Statins have demonstrated efficacy in both primary and secondary stroke prevention over the past two decades.
  • The relationship between low-density lipoprotein cholesterol and cerebrovascular accidents (CVA) is well-established, with statins showing beneficial effects.

Purpose of the Study:

  • To examine the role of statins in stroke prevention.
  • To explore the lipid-lowering and cholesterol-independent pleiotropic effects of statins.
  • To review the current evidence on statin use for dementia prevention, especially vascular dementia.

Main Methods:

  • Review of clinical studies and data on statin use for stroke prevention.
  • Analysis of research on the mechanisms of action of statins, including lipid-lowering and pleiotropic effects.
  • Evaluation of evidence regarding statins and their impact on dementia, particularly vascular causes.

Main Results:

  • Substantial data support statin use for reducing stroke incidence.
  • Statins lower low-density lipoprotein cholesterol, a key factor in cerebrovascular accidents.
  • Statins possess cholesterol-independent pleiotropic properties contributing to neuroprotection.

Conclusions:

  • Statins are effective in reducing the risk of stroke.
  • Pleiotropic effects of statins may offer additional neuroprotective benefits.
  • The role of statins in dementia prevention, particularly vascular dementia, requires further investigation.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.